March 13, 2024 — Lunit, a South Korea-based provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced a significant update on its acquisition of Wellington, New Zealand-based Volpara Health Technologies Ltd., which provides AI-enabled software for personalized screening and early detection of breast cancer.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now